Zusammenfassung
Eine therapeutisch effektive Granulozytentransfusion erfordert mehr als 1010 funktionstüchtige Granulozyten. Diese Zellmenge kann durch zwei Methoden, denen verschiedene Prinzipien zugrunde liegen, von gesunden Spendern gewonnen werden: Durch die Continuous Flow Centrifugation (CFC) und die Filtrations-Leukapherese (FL). Es zeigte sich, daß beide Verfahren unter bestimmten Bedingungen innerhalb von 4 Stunden 2,5 bis 3×1010 therapeutisch gleichwertige Granulozyten zu liefern vermögen, wobei die Kosten der CFC-Granulozyten etwa doppelt so hoch liegen wie die der FL-Granulozyten. Die beste Granulozytenausbeute wurde nach Induktion einer Leukozytose im Spenderblut mit einer 16stündigen Dexamethason-Prämedikation erzielt. Die erhöhte Rate von Nebenwirkungen, wie sie der Transfusion von FL-Granulozyten zugeschrieben wird, ließ sich durch Anwendung der repetitiven Filtrations-Elutions-Leukapherese auf das Niveau der CFC-Granulozyten senken. Die Arbeit definiert außerdem das Leistungsspektrum der CFC, das außer der Granulozytenseparation auch die Gewinnung von Thrombozyten, von Zellen zur Immuntherapie und die Plasmapherese umfaßt.
Summary
More than 1010 viable granulocytes are necessary for a therapeutical effective granulocyte transfusion. This number of cells can be harvested from normal donors by two techniques basing on different principles: continuous flow centrifugation (CFC) and filtration leucapheresis (FL). Our studies demonstrated that, under certain special conditions, the separation potentials of both methods are comparable yielding 2.5 to 3.0×1010 granulocytes within 4 hrs. Granulocyte collection rate was optimal if donors were treated with dexamethasone during 16 hrs prior to the start of the procedure. However, the costs of CFC exceed those of FL by a factor of about two. The increased occurrence of side effects attributed to the transfusion of FL-granulocytes can be reduced to the level of CFC-granulocytes by repetitive filtration-elution leucapheresis minimizing cell damage. The studies define the efficiency spectrum of CFC which in addition to granulocyte separation includes collection of thrombocytes, cells for immunotherapy, and plasmapheresis.
Literatur
Boggs D. R.: Transfusion of neutrophils as prevention of treatment of infection in patients with neutropenia.N. Engl. J. Med. 290, 1055 (1974).
Buckner D., Eisel R. & Perry S.: Blood cell separation in the dog by continuous flow centrifugation.Blood 31, 654 (1968).
Bussel A., Benbunan M., Weil M., Reviron J., Jacquillat C., Boiron M. & Bernard J.: White blood cell transfusions in leukemic patients with severe infections.Cancer Res. 49, 40 (1974).
Clift R. A., Buckner C. D., Williams B. M., Hickman R. O. & Thomas E. D.: Improved granulocyte procurement with the continuous flow centrifuge.Transfusion 13, 276 (1973).
McCredie K. B. & Freireich E. J.: The use of etiocholanolone to increase collection of granulocytes with the IBM blood cell separator.Clin. Invest. 49, 63a (1970).
Djerassi I., Kim J. S., Suvansri U., Mitrakul C. & Ciesielka W.: Continuous flow filtration-leukopheresis.Transfusion (Philad.) 12, 75 (1972).
De Fliedner V., Meuret G. & Senn H. J.: Normal granulocyte collection with a modified repetitive cycle filtration leukapheresis.Blut 29, 265 (1974).
Freireich E. J., Judson G. & Levin R. H.: Separation and collection of leucocytes.Can. Res. 25, 1516 (1965).
Goldstein I. M., Eyre H. J., Terasaki P. I., Henderson E. S. & Graw R. G.: Leukocyte transfusions: Role of leukocyte alloantibodies in determining transfusion response.Transfusion 11, 19 (1971).
Graw R. G., Herzig G. P., Eisel R. J. & Perry S.: Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator.Transfusion (Philad.) 11, 94 (1971).
Graw R., Herzig Jr. G., Eyre H., Goldstein I., Henderson E. & Perry S.: Treatment of gramnegative septicemia in granulocytopoietic patients with normal granulocyte transfusions.Clin. Res. 19, 49 (1971).
Graw R. G., Herzig G., Perry S. & Henderson E. S.: Normal granulocyte transfusion therapy. Treatment of Septicemia due to gramnegative bacteria.N. Engl. J. Med. 287, 367 (1972).
Harris M. B., Djerassi I., Schwartz E. & Root R. K.: Polymorphonuclear leukocytes prepared by continuous flow leukapheresis: viability and function.Blood 44, 707 (1974).
Hersh E. M., Bodey G. P., Nies B. A. et al.: Causes of death in acute leukemia: a ten year study of 414 patients from 1954–1963.JAMA 193, 105 (1965).
Higby D. J., Yates J. W., Henderson E. S. & Holland J. F.: Filtration leukapheresis for granulocyte transfusion therapy.New Engl. J. Med. 292, 761 (1975).
Löwenthal R. M., Grossman L., Goldman J. M., Storring R. A., Buscard N. A., Park D. S., Murphy B. C., Spiers A. S. D. & Galton D. A. G.: Granulocyte transfusions in treatment of infections in patients with acute leukemia and aplastic anaemia.Lancet I, 354 (1975).
Meuret G. & Senn H. J.: Granulozytentransfusion. Ein Überblick.Schweiz. med. Wschr. 105, 225 (1975).
Meuret G., Senn H. J., de Fliedner V. & Fopp M.: Intravascular fate of granulocytes administered by granulocyte transfusions.Acta Haemat. (in press).
Sanel F. T., Aisner J., Tillman C. J., Schiffer C. A. & Wiernik P. H.: Evalution of granulocytes harvested by filtration leukapheresis: Functional, histochemical and ultrastructural studies. In: Goldman J. M. & Löwenthal R. M. (Eds.): Leucocytes: Separation Collection and Transfusion. Academic Press. London-New York-San Francisco, p. 236 (1975).
Schiffer C. A., Buchholz D. H., Aisner J., Betts S. W. & Wernik P. H.: Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukapheresis.Am. J. Med. 58, 373 (1975).
Schwarzenberg L., Mathé G., Amiel J. L., Cattan A., Schneider M. & Schlumberger J. R.: Study of factors determining the usefulness and complications of leukocyte transfusions.Amer J. med. 43, 206 (1967).
Senn H. J.: Die methodische und klinische Problematik der Leukozyten-Transfusion.Dtsch. Med. Wschr. 100, 839 (1975).
Speck B. & Kissling: Die Filtrationsleukopherese.Schweiz. med. Wschr. 104, 1110 (1974).
Author information
Authors and Affiliations
Additional information
Unterstützt durch den Schweizerischen Nationalfonds zur Förderung der wissenschaftlichen Forschung, Projekt-Nr. 3.9200.72.
Rights and permissions
About this article
Cite this article
Meuret, G., Fopp, M., de Fliedner, V. et al. Granulozytengewinnung zur Granulozytentransfusion durch Continuous Flow Centrifugation oder Filtrations-Leukapherese. Blut 32, 79–85 (1976). https://doi.org/10.1007/BF00995935
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00995935